TABLE 2.
Aminoglycoside susceptibilities of clinical P. aeruginosa strains
| Straina | MIC (μg/ml)b
|
||||||||
|---|---|---|---|---|---|---|---|---|---|
| AMI | GEN | KAN | LIV | NEO | PAR | SPC | STR | TOB | |
| K767 | 2 | 4 | 128 | 16 | 64 | 512 | 1,024 | 16 | 1 |
| K2152 (699) | 8 | 8 | 128 | 64 | 128 | 512 | 2,048 | 32 | 4 |
| K2153 (524) | 16 | 16 | 128 | 64 | 128 | 512 | 2,048 | 64 | 4 |
| K2154 (0006-3) | 16 | 512 | 512 | 256 | 256 | 1,024 | >2048 | 256 | 256 |
| K2155 (4420) | 1 | 4 | 16 | 16 | 8 | 32 | 512 | 16 | 1 |
| K2156 (8812-2) | 32 | 32 | 512 | 128 | 128 | 512 | 2,048 | 256 | 8 |
| K2157 (R68) | 64 | 64/128 | 1,024 | 512 | 512 | >2,048 | >2,048 | 256 | 128 |
| K2158 (R69) | 64 | 64 | 1,024 | 512 | 512 | >2,048 | >2,048 | 128 | 32 |
| K2159 (R92) | 8 | 8 | 128 | 16 | 64 | 64 | 64 | 4 | 8 |
| K2160 (R103) | 64 | 32 | 512 | 512 | 128 | 512 | 512 | 128 | 16 |
| K2161 (R109) | 64 | 64 | 1,024 | 256 | 512 | >2,048 | 256 | 64 | 16 |
| K2162 (R115) | 256 | 256 | >2,048 | >2,048 | 1,024 | >2,048 | >2,048 | 256 | 64 |
| K258 (C517M) | 32 | 16 | 512 | 128 | 256 | >2,048 | 2,048 | 64 | 16 |
| K260 (C510M) | 16 | 16 | 128 | 128 | 64 | 256 | 512 | 64 | 4 |
| K2163 (PS380) | 16 | 8 | 128 | 64 | 32 | 256 | 1,024 | 32 | 8 |
a
The designation of the laboratory of K. Poole is given, with the original hospital designation given in parentheses.
b
Abbreviations; AMI, amikacin; GEN, gentamicin; KAN, kanamycin; LIV, lividomycin; NEO, neomycin; PAR, paromomycin; SPC, spectinomycin; STR, streptomycin; TOB, tobramycin.